Cite
HARVARD Citation
Mease, P. et al. (2018). Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study. Annals of the rheumatic diseases. 77 (6), pp. 890-897. [Online].